The board of directors of InnoCare Pharma Limited hereby announced that Dr. Zemin Jason Zhang has tendered his resignation as an independent non-executive Director, a member of the Audit Committee, a member of the Compensation Committee and a member of the Nomination Committee of the Company with effect from 14 July 2023 as he needed more time for his dedication in academic research as a tenured professor at the School of Life Sciences of Peking University. The Board also announces that subsequent to, and concurrent with the resignation of Dr. Zhang as a member of each of the Compensation Committee, the Nomination Committee and the Audit Committee: Dr. Kaixian Chen, an independent non-executive Director, has been appointed as a member of the Compensation Committee; Ms. Lan Hu, an independent non-executive Director, has been appointed as a member of the Nomination Committee; and Mr. Ronggang Xie, a non-executive Director, has been appointed as a member of the Audit Committee.